2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
2013/10/03 by Frank van den Hoogen, F.H.J. van den Hoogen, Dinesh Khanna +70 · 2,920 citations
Medicine · #Dermatology #Inflammatory Myopathies and Dermatomyositis #Internal medicine #Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis #Medicine #Pathology #Rheumatism #Rheumatology #Scleroderma (fungus) #Systemic Sclerosis and Related Diseases
paper · doi:10.1136/annrheumdis-2013-204424
published in Annals of the Rheumatic Diseases 72(11), 1747-1755 (BMJ)
openalex publication_date 2013/10/03 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/05
Citations
Cited by
- Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile
- Spatially informed phenotyping by cyclic-in-situ-hybridization identifies novel fibroblast populations and their pathogenic niches in systemic sclerosis
- Phenotypic patterns and outcomes of connective tissue disease-associated pulmonary arterial hypertension: a Saudi single center experience
- Clinical profiles associated with rapidly progressive interstitial lung disease in antisynthetase syndrome: A multicentric cohort study (TYPASS study)
- Asymmetric dimethylarginine correlates with worsening peripheral microangiopathy in systemic sclerosis
- The frequency and clinical associations of opioid use in systemic sclerosis
- Functional Capacity Incorporating Dynamic Ventilation in Systemic Sclerosis: Agreement Analysis Between Performance on the 6-Minute Walk Test and Glittre–ADL Test
- Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association study
- T Cells Enhance Tissue Complexity and Function to Study Fibrosis in 3D Skin-Like Tissue Models
- Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis
- Echocardiographic characterization of combined postcapillary and precapillary pulmonary hypertension in systemic sclerosis with preserved ejection fraction
- Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee
- Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners
- Plasma GDF‐15 and PSP‐D Predict the Development of Pulmonary Arterial Hypertension in Systemic Sclerosis
- Evaluation of right ventricular function performed by 3d-echocardiography in scleroderma patients
- New Classification Criteria for Systemic Sclerosis (Scleroderma)
- Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies. [europepmc]
- 2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. [europepmc]
- 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. [europepmc]
- Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate). [europepmc]
- Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes. [europepmc]
- Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z. [europepmc]
- Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. [europepmc]
- The tyrosine phosphatase SHP2 controls TGFβ-induced STAT3 signaling to regulate fibroblast activation and fibrosis. [europepmc]
- Systemic sclerosis: state of the art on clinical practice guidelines. [europepmc]
- PU.1 controls fibroblast polarization and tissue fibrosis. [europepmc]
- Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma. [europepmc]
- Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. [europepmc]
- Distinct phenotype of CD4 + T cells driving celiac disease identified in multiple autoimmune conditions. [europepmc]
- CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis. [europepmc]
- Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease. [europepmc]
- Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis. [europepmc]
- Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study. [europepmc]
- Systemic sclerosis - multidisciplinary disease: clinical features and treatment. [europepmc]
- Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. [europepmc]
- Profibrotic Activation of Human Macrophages in Systemic Sclerosis. [europepmc]
- Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial. [europepmc]
- A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis. [europepmc]
- Dermal fibroblasts have different extracellular matrix profiles induced by TGF-β, PDGF and IL-6 in a model for skin fibrosis. [europepmc]
- LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma. [europepmc]
- Systemic sclerosis. [europepmc]